|Bid||17.30 x 800|
|Ask||17.65 x 1400|
|Day's range||17.20 - 17.53|
|52-week range||13.59 - 23.25|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||20.35|
|Earnings date||23 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||07 Oct 2008|
|1y target est||21.17|
While Veradigm Inc. ( NASDAQ:MDRX ) might not be the most widely known stock at the moment, it led the NASDAQGS gainers...
CHICAGO, January 30, 2023--Veradigm (NASDAQ: MDRX) announced today that Veradigm Network EHR Data is now available within the OMOP CDM format. Veradigm Network EHR is a complete statistically deidentified dataset containing three integrated EHR sources. This source dataset is now available in the OMOP CDM version 5.3.1.
Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations to biopharmaceutical customers.